These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14734798)

  • 1. Characterization of N-terminal interferon tau mutants: P26L affords enhanced activity and lack of toxicity.
    Shorts LH; Dancz CE; Shupp JW; Pontzer CH
    Exp Biol Med (Maywood); 2004 Feb; 229(2):194-202. PubMed ID: 14734798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function relationships in the interferon-tau (IFN-tau). Changes in receptor binding and in antiviral and antiproliferative activities resulting from site-directed mutagenesis performed near the carboxyl terminus.
    Li J; Roberts RM
    J Biol Chem; 1994 Oct; 269(40):24826-33. PubMed ID: 7929162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure/function studies with interferon tau: evidence for multiple active sites.
    Pontzer CH; Ott TL; Bazer FW; Johnson HM
    J Interferon Res; 1994 Jun; 14(3):133-41. PubMed ID: 7930760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities.
    Subramaniam PS; Khan SA; Pontzer CH; Johnson HM
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12270-4. PubMed ID: 8618883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid differences in interferon-tau (IFN-τ) of Bos taurus Coreanae and Holstein.
    Kang D; Ryoo S; Chung B; Lee J; Park S; Han J; Jeong S; Rho G; Hong J; Bae S; Kang T; Kim S; Kim S
    Cytokine; 2012 Aug; 59(2):273-9. PubMed ID: 22578803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A type I ovine interferon with limited similarity to IFN-alpha, IFN-omega and IFN-tau: gene structure, biological properties and unusual species specificity.
    Liu L; Leaman DW; Bixby JA; Roberts RM
    Biochim Biophys Acta; 1996 May; 1294(1):55-62. PubMed ID: 8639714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cross-species antiviral activities of different IFN-tau subtypes on bovine, murine, and human cells: contradictory evidence for therapeutic potential.
    Alexenko AP; Ealy AD; Roberts RM
    J Interferon Cytokine Res; 1999 Dec; 19(12):1335-41. PubMed ID: 10638702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of the signature six carboxyl amino acid tail from ovine interferon-tau does not affect biological activity.
    Ealy AD; Alexenko AP; Keisler DH; Roberts RM
    Biol Reprod; 1998 Jun; 58(6):1463-8. PubMed ID: 9623607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of variants of interferon-tau with mutations near the carboxyl terminus on luteal life span in sheep.
    Niswender KD; Li J; Powell MR; Loos KR; Roberts RM; Keisler DH; Smith MF
    Biol Reprod; 1997 Jan; 56(1):214-20. PubMed ID: 9002652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiproliferative and antiviral activities of IFN-tau variants in human cells.
    Alexenko AP; Leaman DW; Li J; Roberts RM
    J Interferon Cytokine Res; 1997 Dec; 17(12):769-79. PubMed ID: 9452365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the expressed forms of ovine interferon-tau in the periimplantation conceptus: sequence relationships and comparative biological activities.
    Winkelman GL; Roberts RM; James Peterson A; Alexenko AP; Ealy AD
    Biol Reprod; 1999 Dec; 61(6):1592-600. PubMed ID: 10570008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of ovine interferon-tau at 2.1 A resolution.
    Radhakrishnan R; Walter LJ; Subramaniam PS; Johnson HM; Walter MR
    J Mol Biol; 1999 Feb; 286(1):151-62. PubMed ID: 9931256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different ovine interferon-tau genes are not expressed identically and their protein products display different activities.
    Ealy AD; Green JA; Alexenko AP; Keisler DH; Roberts RM
    Biol Reprod; 1998 Feb; 58(2):566-73. PubMed ID: 9475415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human IFN-alpha protein engineering: the amino acid residues at positions 86 and 90 are important for antiproliferative activity.
    Hu R; Bekisz J; Schmeisser H; McPhie P; Zoon K
    J Immunol; 2001 Aug; 167(3):1482-9. PubMed ID: 11466368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulating functions of recombinant ovine interferon tau: potential for therapy in multiple sclerosis and autoimmune disorders.
    Khan OA; Jiang H; Subramaniam PS; Johnson HM; Dhib-Jalbut SS
    Mult Scler; 1998 Apr; 4(2):63-9. PubMed ID: 9599335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovine IFN-tau modulates the expression of MHC antigens on murine cerebrovascular endothelial cells and inhibits replication of Theiler's virus.
    Tennakoon DK; Smith R; Stewart MD; Spencer TE; Nayak M; Welsh CJ
    J Interferon Cytokine Res; 2001 Oct; 21(10):785-92. PubMed ID: 11710989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon signaling is dependent on specific tyrosines located within the intracellular domain of IFNAR2c. Expression of IFNAR2c tyrosine mutants in U5A cells.
    Wagner TC; Velichko S; Vogel D; Rani MR; Leung S; Ransohoff RM; Stark GR; Perez HD; Croze E
    J Biol Chem; 2002 Jan; 277(2):1493-9. PubMed ID: 11682488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid substitutions in loop BC and helix C affect antigenic properties of helix D in hybrid IFN-alpha21a/alpha2c molecules.
    Schmeisser H; Hu R; Kontsek P; Bekisz J; Zoon K
    J Interferon Cytokine Res; 2002 Apr; 22(4):463-72. PubMed ID: 12034029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-tau: a novel subtype I IFN1. Structural characteristics, non-ubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities.
    Martal JL; Chêne NM; Huynh LP; L'Haridon RM; Reinaud PB; Guillomot MW; Charlier MA; Charpigny SY
    Biochimie; 1998; 80(8-9):755-77. PubMed ID: 9865498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of monoclonal antibodies to interferon-tau.
    Swann SL; Bazer FW; Villarete LH; Chung A; Pontzer CH
    Hybridoma; 1999 Oct; 18(5):399-405. PubMed ID: 10600026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.